miR-27a acts as an oncogene by silencing MAP2K4, which is an important tumor suppressor inhibiting cell proliferation and migration via the JNK/p38 signaling pathway downstream of the TGF-β/TAK1 pathway (59). This evidence concerns the gene TGFB1 and neoplasm.